The American Cancer Society estimates about 77,420 people will be diagnosed with non-Hodgkin lymphoma in 2020. Non-Hodgkin lymphoma is a blood cancer that affects white blood cells, lymphocytes, that play a critical role in the immune system.
Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome.
Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By taking part in a clinical trial, you can find the best treatment for your non-Hodgkin’s lymphoma and help others who are struggling with non-Hodgkin lymphoma. Getting access to the right clinical trials and right treatments should not have to be overwhelming. That is why Massive Bio uses the clinical trial matching service to match non-Hodgkin lymphoma patients to the right clinical trials based on the stage of disease, biomarker status, geographical location, and past medical history.
Why Join A Non-Hodgkin’s Lymphoma Clinical Trial?
New drugs and treatments are available for non-Hodgkin’s lymphoma patients in clinical trials, which are being evaluated by the FDA to ensure the safety and effectiveness of the treatment. Before their approval, clinical trials provide early access to these therapies to benefit current patients and further research. Massive Bio’s SYNERGY-AI Clinical Trial Matching System matches patients to clinical trials based on their unique cancer case. More than 100 data points are used to find matching trials including the type of cancer, location, stage of the disease, and any present biomarkers.
Effects of Non-Hodgkin’s Lymphoma
Find Non-Hodgkin’s Lymphoma Clinical Trials
Massive Bio’s virtual matching system will do all the work for you. Our team finds the most suitable clinical trial options for you, avoiding travel until a trial is picked and the enrollment process is complete. When your results with matching clinical trials are ready and delivered directly via email, our experienced patient advocate will help you through the process of enrolling in the trial and will even help get over any issues preventing enrollment throughout the process. Our goal is helping cancer patients find the latest in cancer treatment to create positive outcomes for their case. Contact us today to learn more about how we help cancer patients receive early access to new treatments in clinical trials.
Find a Clinical Trial
Do You Have Any Questions?
- Be one step closer to finding non-Hodgkin's lymphoma treatments.
- Get a second opinion from US oncologists, without leaving your home.
- If you have relapsed, or current therapy has failed, there are more options for you.
- Access to clinical trials & immunotherapy treatment options.
Join this Non-Hodgkin Lymphoma Facebook Group for Community Support
Patient's recently diagnosed or relapsed with Non-Hodgkin Lymphoma may wonder what the right next step to take is. Join a community of others who are going through Non-Hodgkin Lymphoma to discuss questions, concerns, and share stories.
The Facebook live event, COVID-19 and Cancer Patients: What You Should Know, was hosted by Massive Bio on January 13, 2021. The live event featured interviews about COVID-19 and its effect on cancer patients from Massive Bio medical experts. Guests included Massive Bio’s Co-founder and Chief Medical Advisor, Dr. Arturo Loaiza-Bonilla, MD; Chief Nursing Officer, …
Free Matching to Cancer Clinical Trials Your match report contains a detailed list of cervical cancer clinical trials that you may be eligible to enroll in to receive unique and nonconventional treatment. Standard treatment is not the only option. A patient advocate will review your report with you to answer any questions or concerns you may …
The American Cancer Society estimates about 77,420 people will be diagnosed with Non-Hodgkin’s Lymphoma (NHL) in 2020. Non-Hodgkin’s Lymphoma is a type of cancer that first begins in the lymphatic system, which is the system in the body that fights against disease and infections. It is the most common type of lymphoma. In NHL, abnormal …
Frequently Asked Questions Related to Non-Hodgkin’s Lymphoma
- The CTMS can be accessed on our website and through our mobile app, SYNERGY-AI Cancer Trial Finder, which is available on both Google Play and the IOS App Store.
- We request patients’ medical records directly from healthcare providers through fax.
- We send clinical trial matching reports directly to patients within 7-10 business days of receiving the medical records.
- We will contact you to discuss your clinical trial match report and the next steps needed in order to enroll in the matching trial.
- The process is entirely virtual until the enrollment process is completed, and the first appointment is scheduled at the clinical trial site. Therefore, the CTMS helps avoid unnecessary travel until the patient is ready to begin the trial.
Once you receive your match results, an oncology case manager will call you to discuss your options and decide if a trial is right for your case. Massive Bio only advocates for patients to enroll into a trial if it has a chance to benefit your specific cancer case. Once a trial is chosen, our team will handle all logistics and facilitate enrollment until the process is completed.